A biotechnology company based in the United Kingdom has licensed three patents and applications from Vanderbilt University for its Organs-on-Chips products.

CN Bio Innovations Ltd., a spinoff from Oxford University, secured a combination of exclusive and non-exclusive rights to microfluid technologies developed by Professor John Wikswo, Gordon A. Cain University and his group. Wikswo, a biomedical engineering professor, also is the A. B. Learned Professor of Living State Physics and founding director of the Vanderbilt Institute for Integrative Biosystems Research and Education (VIIBRE).

“With these additional technologies the precision and control we can achieve over conditions in the organ-mimics open up exciting new possibilities for modelling human biology and disease in the laboratory,” David Hughes, CN Bio’s Chief Technical Officer, said in a statement.

The Vanderbilt Center for Technology Transfer and Commercialization announced the licensing arrangement this week… Continue reading.